AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca biogenic CO2 emissions (tCO2e)
Sustainability Data Annex — Greenhouse Gas Emissions
Latest, FY2025
105,850
Period ended Dec 31, 2025
Change on a year earlier
+39.3%
75,978 in FY2024
History
5 years
Since FY2015
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Biogenic CO2 emissions (tCO2e) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 105,850 | +39.3% | Sustainability Data Annex 2025 ↗ |
| FY2024 | Dec 31, 2024 | 75,978 | +160.2% | Sustainability Data Annex 2025 ↗ |
| FY2023 | Dec 31, 2023 | 29,201 | +205.6% | Sustainability Data Annex 2025 ↗ |
| FY2022 | Dec 31, 2022 | 9,556 | – | Sustainability Data Annex 2024 ↗ |
| FY2015 | Dec 31, 2015 | 2,822 | – | Sustainability Data Annex 2025 ↗ |
Cite this data
StockData. (2026). AstraZeneca Biogenic CO2 emissions (tCO2e), annual FY2015–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/esg_biogenic
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.